Hyperplasia

Sep 23, 2019

Benign Prostatic Hyperplasia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Mar 25, 2019

Spruce Biosciences Achieves Proof of Concept in Phase 2 Study of Tildacerfont in Congenital Adrenal Hyperplasia

Mar 08, 2019

Spruce Biosciences Announces Presentation of Positive Topline Data from Phase 2 Study of Tildacerfont (SPR001) in Congenital Adrenal Hyperplasia at the 2019 Annual Meeting of the Endocrine Society (ENDO)

Oct 30, 2018

Global Benign Prostatic Hyperplasia Market and Competitive Landscape Report 2018

Sep 17, 2018

Congenital Adrenal Hyperplasia Epiomic Epidemiology Forecasts 2018-2028

Jul 12, 2018

Global Benign Prostatic Hyperplasia Therapeutics Market Expected to Reach $20,097 Million by 2025 | Allied Market Research

Mar 05, 2018

Symic Bio Announces Results of Locally-Administered Therapeutic SB-030 in Preclinical Model of Vascular Intervention

Feb 15, 2018

Global Benign Prostatic Hyperplasia Market Spotlight 2017-2025

Jan 05, 2018

Spruce Biosciences Receives EMA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia

Nov 28, 2017

Global Benign Prostatic Hyperplasia Market and Competitive Landscape 2017-2025